BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9620558)

  • 61. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.
    Furnari FB; Lin H; Huang HS; Cavenee WK
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12479-84. PubMed ID: 9356475
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
    Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
    Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
    Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
    Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple inositol polyphosphate phosphatase: evolution as a distinct group within the histidine phosphatase family and chromosomal localization of the human and mouse genes to chromosomes 10q23 and 19.
    Chi H; Tiller GE; Dasouki MJ; Romano PR; Wang J; O'keefe RJ; Puzas JE; Rosier RN; Reynolds PR
    Genomics; 1999 Mar; 56(3):324-36. PubMed ID: 10087200
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.
    Robertson GP; Furnari FB; Miele ME; Glendening MJ; Welch DR; Fountain JW; Lugo TG; Huang HJ; Cavenee WK
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9418-23. PubMed ID: 9689095
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
    García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
    Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
    [TBL] [Abstract][Full Text] [Related]  

  • 70. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.
    Myers MP; Stolarov JP; Eng C; Li J; Wang SI; Wigler MH; Parsons R; Tonks NK
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9052-7. PubMed ID: 9256433
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast.
    Li L; Ernsting BR; Wishart MJ; Lohse DL; Dixon JE
    J Biol Chem; 1997 Nov; 272(47):29403-6. PubMed ID: 9367992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Severe Lhermitte-Duclos disease with unique germline mutation of PTEN.
    Sutphen R; Diamond TM; Minton SE; Peacocke M; Tsou HC; Root AW
    Am J Med Genet; 1999 Feb; 82(4):290-3. PubMed ID: 10051160
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutation analysis of the PTEN / MMAC1 gene in Japanese patients with Cowden disease.
    Sawada T; Hamano N; Satoh H; Okada T; Takeda Y; Mabuchi H
    Jpn J Cancer Res; 2000 Jul; 91(7):700-5. PubMed ID: 10920277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of splicing defects in PTEN leading to exon skipping or partial intron retention in Cowden syndrome.
    Celebi JT; Wanner M; Ping XL; Zhang H; Peacocke M
    Hum Genet; 2000 Sep; 107(3):234-8. PubMed ID: 11071384
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alternative splicing of the Drosophila PTEN gene.
    Smith A; Smith A; Alrubaie S; Coehlo C; Leevers SJ; Ashworth A
    Biochim Biophys Acta; 1999 Oct; 1447(2-3):313-7. PubMed ID: 10542333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of nonsense mutations on PTEN mRNA stability.
    Raizis AM; Ferguson MM; George PM
    Hum Genet; 2000 Jul; 107(1):24-7. PubMed ID: 10982030
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alterations of the PPP1R3 gene in human cancer.
    Kohno T; Takakura S; Yamada T; Okamoto A; Tanaka T; Yokota J
    Cancer Res; 1999 Sep; 59(17):4170-4. PubMed ID: 10485448
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A study of the PTEN/MMAC1 gene in 136 breast cancer families.
    Chen J; Lindblom P; Lindblom A
    Hum Genet; 1998 Jan; 102(1):124-5. PubMed ID: 9490290
    [No Abstract]   [Full Text] [Related]  

  • 79. Alterations of the MMAC1/PTEN gene in lymphoid malignancies.
    Grønbaek K; Zeuthen J; Guldberg P; Ralfkiaer E; Hou-Jensen K
    Blood; 1998 Jun; 91(11):4388-90. PubMed ID: 9596690
    [No Abstract]   [Full Text] [Related]  

  • 80. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
    Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
    J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.